Barszczewska, Olga; Chami, Ralph; Piechota, Anna - In: Comparative economic research : Central and Eastern Europe 23 (2020) 2, pp. 103-115
The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...